re: Ann: DADI Completes all Approvals for $24... I would like to know what the catalyst will be to move the SP from the range we currently have been in for some time?
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
